Equities analysts predict that Sotera Health (NYSE:SHC) will announce sales of $207.64 million for the current fiscal quarter, according to Zacks. Four analysts have made estimates for Sotera Health’s earnings, with estimates ranging from $206.61 million to $208.70 million. The business is expected to report its next earnings results on Tuesday, June 8th.
According to Zacks, analysts expect that Sotera Health will report full year sales of $904.43 million for the current fiscal year, with estimates ranging from $900.00 million to $907.17 million. For the next fiscal year, analysts expect that the firm will report sales of $998.86 million, with estimates ranging from $979.00 million to $1.01 billion. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that follow Sotera Health.
Sotera Health (NYSE:SHC) last released its earnings results on Monday, March 8th. The company reported $0.09 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.07 by $0.02. The business had revenue of $216.90 million for the quarter, compared to analysts’ expectations of $212.29 million. The company’s revenue for the quarter was up 12.1% compared to the same quarter last year.
Shares of SHC traded up $0.07 on Monday, hitting $26.02. 7,126 shares of the stock traded hands, compared to its average volume of 1,382,204. The firm has a 50 day simple moving average of $26.41. Sotera Health has a one year low of $23.84 and a one year high of $30.38.
In related news, SVP Matthew J. Klaben sold 41,952 shares of Sotera Health stock in a transaction on Monday, March 22nd. The shares were sold at an average price of $26.12, for a total transaction of $1,095,786.24. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Pincus & Co. Warburg sold 13,512,582 shares of Sotera Health stock in a transaction on Monday, March 22nd. The shares were sold at an average price of $26.12, for a total transaction of $352,948,641.84. The disclosure for this sale can be found here. In the last three months, insiders have sold 14,371,973 shares of company stock valued at $375,395,935.
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Citigroup Inc. purchased a new position in shares of Sotera Health during the 4th quarter valued at $26,000. Ancora Advisors LLC purchased a new position in shares of Sotera Health during the 4th quarter valued at $27,000. Victory Capital Management Inc. purchased a new stake in Sotera Health in the 4th quarter worth $217,000. Jane Street Group LLC purchased a new stake in Sotera Health in the 4th quarter worth $315,000. Finally, Boston Partners purchased a new stake in Sotera Health in the 4th quarter worth $409,000.
Sotera Health Company Profile
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the United States and internationally. Its sterilization services include gamma and electron beam irradiation, and EO processing; and lab services comprise analytical chemistry, medical device, and pharmaceutical lab testing, as well as microbiology testing.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.